PAMELA SCHREURS: Open Payments
NPI 1336866748 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 17 payments from 8 companies in 2025. Trend: 2023 $464 · 2024 $775 · 2025 $397
Food & beverage: $369Education: $27
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 2 | $68 |
| Alkermes, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| ABBVIE INC. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
Products named: INVEGA SUSTENNA, COBENFY, VRAYLAR, UZEDY, FANAPT, VIVITROL, ARISTADA, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
